NoBACZ is pioneering a novel, new precision bandaging platform for the veterinary and human market.
NoBACZ has raised $6.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2025.
NoBACZ's investors include Parkwalk Advisors, The Yield Lab, University of Cambridge, The FSE Group, ACF Investors.
NoBACZ is headquartered in Cambridge, United Kingdom.
NoBACZ is pioneering a novel, new precision bandaging platform for the veterinary and human market.
NoBACZ is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NoBACZ — Funding & Investors." VCBacked, September 29, 2025, https://www.vcbacked.co/company/nobacz. Accessed September 29, 2026.
VCBacked. (2025). NoBACZ — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/nobacz
{{cite web |title=NoBACZ — Funding & Investors |url=https://www.vcbacked.co/company/nobacz |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated